Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-04-30
1983-05-24
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544 22, A61K 31545, C07D50134
Patent
active
043850545
ABSTRACT:
Compounds of the general formula ##STR1## (wherein R represents a methyl or 2-chloroethyl group and * represents an asymmetric carbon atom). The above compounds are useful as orally administrable antibiotics.
REFERENCES:
patent: 3962227 (1976-06-01), Chauvette
patent: 3971778 (1976-07-01), Cook et al.
patent: 3974153 (1976-08-01), Cook et al.
patent: 4011215 (1977-03-01), Cook et al.
patent: 4103084 (1978-07-01), Bradshaw et al.
patent: 4122259 (1978-10-01), Humber
patent: 4162360 (1979-07-01), Bradshaw et al.
patent: 4267320 (1981-05-01), Gregson et al.
Gregson Michael
O'Callaghan Cynthia H.
Coughlan, Jr. Paul M.
Glaxo Group Limited
LandOfFree
1-Acetoxyethyl-3-(2-chloroethylcarbamoyloxymet hyl)-7-[2-(fur-2- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-Acetoxyethyl-3-(2-chloroethylcarbamoyloxymet hyl)-7-[2-(fur-2-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-Acetoxyethyl-3-(2-chloroethylcarbamoyloxymet hyl)-7-[2-(fur-2- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2146015